Related Experiment Video
Updated: Oct 21, 2025

Multi-step Preparation Technique to Recover Multiple Metabolite Compound Classes for In-depth and Informative Metabolomic Analysis
Published on: July 11, 2014
Valproic acid autoinduction: a case-based review
Sean Bennett1, Mujeeb U Shad2,3,4
1Samaritan Health Services, Corvallis, OR, USA.
Valproic acid (VPA) autoinduction, though rare, can occur due to complex metabolism and drug interactions. Monitoring free VPA levels is crucial for optimizing treatment and preventing adverse outcomes in patients.
Area of Science:
- Pharmacology
- Clinical Pharmacy
Background:
- Valproic acid (VPA) is known to induce the metabolism of other drugs.
- Clinical reports of VPA autoinduction are infrequent, potentially due to underreporting or complexity in recognizing it.
Purpose of the Study:
- To review published cases and present a new case of VPA autoinduction.
- To enhance clinician awareness of VPA autoinduction and its underlying mechanisms.
Main Methods:
- Comprehensive literature search for VPA autoinduction cases.
- Case-based review comparing clinical data from published and new cases.
Main Results:
- VPA autoinduction is a rare but clinically relevant phenomenon.
- Increased VPA elimination can be influenced by drug interactions, genetic polymorphisms, and protein displacement.
- Protein displacement reactions increase the free, metabolizable fraction of VPA, posing diagnostic challenges.
Conclusions:
- VPA autoinduction may be underreported due to complex metabolism and recognition challenges.
- Monitoring free VPA fractions alongside total levels is recommended for challenging cases.
- Enhanced awareness and monitoring can optimize VPA treatment and prevent serious outcomes.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Therapeutic Drug Monitoring: Overview and Classification

